Liraglutide in adults with type 2 diabetes: global perspective on safety, efficacy and patient preference.
about
Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea and/or One or Two Other Oral Antidiabetic Drugs (JDDM 33)GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial.Safety, tolerability and efficacy of lixisenatide as monotherapy in Japanese patients with type 2 diabetes mellitus: An open-label, multicenter study.
P2860
Liraglutide in adults with type 2 diabetes: global perspective on safety, efficacy and patient preference.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Liraglutide in adults with typ ...... ficacy and patient preference.
@ast
Liraglutide in adults with typ ...... ficacy and patient preference.
@en
type
label
Liraglutide in adults with typ ...... ficacy and patient preference.
@ast
Liraglutide in adults with typ ...... ficacy and patient preference.
@en
prefLabel
Liraglutide in adults with typ ...... ficacy and patient preference.
@ast
Liraglutide in adults with typ ...... ficacy and patient preference.
@en
P2860
P356
P1476
Liraglutide in adults with typ ...... ficacy and patient preference.
@en
P2093
Daisuke Yabe
Yutaka Seino
P2860
P356
10.4137/CMED.S5976
P577
2011-09-13T00:00:00Z